Search Results

FINAL Chief Executive Designate - Stakeholder Briefing - 11 November 2021.pdf

Dr Chris Clayton appointment; Chief Executive JUCD

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Disclosure Ref 202262 - Ethnic minority categories used for patients.pdf

FOI Disclosure

DCHS Glasses Claim Authorisation Form

Glasses Claim Authorisation

HR24 Formal Notification of Return Date from Maternity Leave.docx

Be ALERT a Needlestick hurts - email signature

Patient under Barrier Precautions Poster.docx

Disclsoure Ref 2022105 - Patient transport costs.pdf

FOI disclosure

Information governance newsletter - August 2022.docx

IG Newsletter August 2022

APPENDIX 3 Paternity Partner Leave Flow Chart for Managers.docx